A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
for Aortic Stenosis
Drug: Pelacarsen
Sites in Albany, New York +31 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 50 - 80
Code: NCT05646381·Phase 2·Recruiting·Listed Dec 2022